These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Our experience with orthopedic surgery in hemophiliacs. Poenaru DV; Serban M; Branea IL; Pătraşcu JM Srp Arh Celok Lek; 2006; 134(3-4):143-50. PubMed ID: 16915756 [TBL] [Abstract][Full Text] [Related]
23. [Hemophilic arthropathy of the knee joint. Treatment of hemorrhages of the knee-joint and their consequences]. Landbeck G; Kurme A Monatsschr Kinderheilkd (1902); 1970 Feb; 118(2):29-41. PubMed ID: 5522402 [No Abstract] [Full Text] [Related]
24. Intraarticular bleeding in children with hemophilia: the prevention of arthropathy. Gregosiewicz A; Wośko I; Kandzierski G J Pediatr Orthop; 1989; 9(2):182-5. PubMed ID: 2494223 [TBL] [Abstract][Full Text] [Related]
25. Total knee arthroplasty in hemophilic arthropathy: efficiency of clotting factor usage in multijoint procedures. Schild FJ; Mauser-Bunschoten EP; Verbout AJ; Van Rinsum AC; Roosendaal G J Thromb Haemost; 2009 Oct; 7(10):1741-3. PubMed ID: 19682237 [No Abstract] [Full Text] [Related]
26. Recombinant VIIa concentrate in the management of bleeding following prothrombin complex concentrate-related myocardial infarction in patients with haemophilia and inhibitors. Hough RE; Hampton KK; Preston FE; Channer KS; West J; Makris M Br J Haematol; 2000 Dec; 111(3):974-9. PubMed ID: 11122162 [TBL] [Abstract][Full Text] [Related]
27. Hemostatic effect of recombinant factor VIIa, NN1731 and recombinant factor VIII on needle-induced joint bleeding in hemophilia A mice. Ovlisen K; Kristensen AT; Valentino LA; Hakobyan N; Ingerslev J; Tranholm M J Thromb Haemost; 2008 Jun; 6(6):969-75. PubMed ID: 18363814 [TBL] [Abstract][Full Text] [Related]
28. Clinical efficacy of prothrombin complex concentrates and recombinant factor VIIa in the treatment of bleeding episodes in patients with factor VII and IX inhibitors. Barthels M Thromb Res; 1999 Aug; 95(4 Suppl 1):S31-8. PubMed ID: 10499907 [TBL] [Abstract][Full Text] [Related]
29. Bypassing agent prophylaxis in people with hemophilia A or B with inhibitors. Chai-Adisaksopha C; Nevitt SJ; Simpson ML; Janbain M; Konkle BA Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011441. PubMed ID: 28944952 [TBL] [Abstract][Full Text] [Related]
30. Advances in hemophilia: experimental aspects and therapy. Rodriguez NI; Hoots WK Hematol Oncol Clin North Am; 2010 Feb; 24(1):181-98. PubMed ID: 20113902 [TBL] [Abstract][Full Text] [Related]
35. Synovectomy of the knee for hemophilic arthropathy. Montane I; McCollough NC; Lian EC J Bone Joint Surg Am; 1986 Feb; 68(2):210-6. PubMed ID: 3944160 [TBL] [Abstract][Full Text] [Related]
36. The management of musculoskeletal problems in hemophilia. Part I. Principles of medical management of hemophilia. McMillan CW; Greene WB; Blatt PM; White GC; Roberts HR Instr Course Lect; 1983; 32():210-6. PubMed ID: 6443730 [TBL] [Abstract][Full Text] [Related]
37. Hemophilic arthropathy: Current knowledge and future perspectives. Gualtierotti R; Solimeno LP; Peyvandi F J Thromb Haemost; 2021 Sep; 19(9):2112-2121. PubMed ID: 34197690 [TBL] [Abstract][Full Text] [Related]
38. Prophylactic treatment in hemophilic patients with inhibitors. Haya S Blood Coagul Fibrinolysis; 2019 Sep; 30(1S Suppl 1):S14-S18. PubMed ID: 31517711 [TBL] [Abstract][Full Text] [Related]
39. Synovectomy in the treatment of hemophilic arthropathy. Dyszy-Laube B; Kaminski W; Gizycka I; Kaminska D; Sekowska-Zmuda J; Ludert E J Pediatr Surg; 1974 Feb; 9(1):123-5. PubMed ID: 4811249 [No Abstract] [Full Text] [Related]